563 related articles for article (PubMed ID: 27235935)
1. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.
Coelho A; Oliveira R; Cruz F; Cruz CD
Exp Neurol; 2016 Nov; 285(Pt B):159-166. PubMed ID: 27235935
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
3. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
Munoz A; Somogyi GT; Boone TB; Smith CP
Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis.
Coelho A; Oliveira R; Rossetto O; Cruz CD; Cruz F; Avelino A
Eur J Pain; 2014 Nov; 18(10):1480-9. PubMed ID: 24756904
[TBL] [Abstract][Full Text] [Related]
5. Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action.
Coelho A; Cruz F; Cruz CD; Avelino A
Eur Urol; 2012 Jun; 61(6):1178-84. PubMed ID: 22306320
[TBL] [Abstract][Full Text] [Related]
6. Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity.
Oliveira R; Coelho A; Franquinho F; Sousa MM; Cruz F; D Cruz C
Neurourol Urodyn; 2019 Aug; 38(6):1540-1550. PubMed ID: 31180583
[TBL] [Abstract][Full Text] [Related]
7. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
8. Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
Huynh Le Maux A; Pignol B; Behr-Roussel D; Blachon JL; Chabrier PE; Compagnie S; Picaut P; Bernabé J; Giuliano F; Denys P
Toxins (Basel); 2015 Dec; 7(12):5462-71. PubMed ID: 26694464
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
Cruz CD; Charrua A; Vieira E; Valente J; Avelino A; Cruz F
Exp Neurol; 2008 Dec; 214(2):301-8. PubMed ID: 18824169
[TBL] [Abstract][Full Text] [Related]
10. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
Chen G; Liao L
Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
[TBL] [Abstract][Full Text] [Related]
11. Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.
Linsenmeyer TA
J Spinal Cord Med; 2013 Sep; 36(5):402-19. PubMed ID: 23941788
[TBL] [Abstract][Full Text] [Related]
12. [Neurogenic detrusor overactivity - botulinum toxin type A injections improve quality of life].
Braun M
Aktuelle Urol; 2013 May; 44(3):177-8. PubMed ID: 23712270
[No Abstract] [Full Text] [Related]
13. Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity.
Kaviani A; Khavari R
Urol Clin North Am; 2017 Aug; 44(3):463-474. PubMed ID: 28716326
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.
Tow AM; Toh KL; Chan SP; Consigliere D
Ann Acad Med Singap; 2007 Jan; 36(1):11-7. PubMed ID: 17285181
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
Chen YC; Kuo HC
Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
[TBL] [Abstract][Full Text] [Related]
16. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury.
Jia C; Liao LM; Chen G; Sui Y
Spinal Cord; 2013 Jun; 51(6):487-90. PubMed ID: 23357928
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin treatment for bladder dysfunction.
Santos-Silva A; da Silva CM; Cruz F
Int J Urol; 2013 Oct; 20(10):956-62. PubMed ID: 23634720
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury.
Hui C
J Pediatr Surg; 2020 Dec; 55(12):2736-2739. PubMed ID: 32571538
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011.
Kanai A; Zabbarova I; Oefelein M; Radziszewski P; Ikeda Y; Andersson KE
Neurourol Urodyn; 2012 Mar; 31(3):300-8. PubMed ID: 22275187
[TBL] [Abstract][Full Text] [Related]
20. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity.
Hui C; Keji X; Chonghe J; Ping T; Rubiao O; Jianweng Z; Xiangrong D; Liling Z; Maping H; Qingqing L; Qiuling L; Jiebing H; Tanghai H
Spinal Cord; 2016 Jan; 54(1):46-50. PubMed ID: 26261074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
